Two million doses of AstraZeneca COVID vaccine set to be supplied every week by mid-January in UK: Report

Published On 2021-01-02 08:23 GMT   |   Update On 2021-01-02 08:23 GMT

New Delhi: About two million doses of COVID-19 vaccine developed by Oxford University and AstraZeneca are set to be supplied every week by the middle of January in the United Kingdom, The Times reported.AstraZeneca expects to supply two million doses of the vaccine in total by next week, the newspaper reported, citing an unnamed member of the Oxford-AstraZeneca team. "The plan is then to build...

Login or Register to read the full article

New Delhi: About two million doses of COVID-19 vaccine developed by Oxford University and AstraZeneca are set to be supplied every week by the middle of January in the United Kingdom, The Times reported.

AstraZeneca expects to supply two million doses of the vaccine in total by next week, the newspaper reported, citing an unnamed member of the Oxford-AstraZeneca team. "The plan is then to build it up fairly rapidly - by the third week of January we should get to two million a week," the report added.

The company was not immediately available to respond to a Reuters request for comment.

The report comes after Britain on Wednesday approved the Oxford-AstraZeneca COVID-19 vaccine, hoping that rapid action will help it stem a record surge of infections driven by a highly contagious form of the virus.

Prime Minister Boris Johnson has ordered 100 million doses for the country as part of an agreement with the company. The company had said it aims to supply millions of doses in the first quarter, adding that first vaccinations are slated to begin this year.

Read also: Indonesia to strike vaccine deals with Pfizer, AstraZeneca

Britain, which has recorded more than 50,000 new daily cases of COVID-19 for the last four days, is dealing with a rapid spread of a much more infectious variant of the coronavirus. As of Friday, the UK has recorded 53,285 new COVID-19 cases and 613 deaths.

Read also: CDSCO Committee clears AstraZeneca vax, DCGI nod awaited



Tags:    
Article Source : Reuters

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News